MedPath

The effect of Zinc supplementation on sexual satisfaction, sexual function and testosterone level in postmenopausal wome

Phase 3
Recruiting
Conditions
Postmenopausal Sexual Disorders.
Other sexual disorders
Registration Number
IRCT20191007045010N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
116
Inclusion Criteria

Married women
At least one year and a maximum of 5 years since the last menstrual period
Minimum literacy
49 years and up
People whose FSFI score is <26.5
Those who achieved according ton Larsson questionnaire of sexual dissatisfaction (score of 50 and below), low sexual satisfaction (score of 51-75)
People whose fasting plasma zinc is less than 62 micrograms / d

Exclusion Criteria

Having at least one known chronic illness
Current experience of mental disorders and depression in the sample of the researcher and his wife
Addiction, alcohol abuse and smoking
Drugs affecting sexual function
Those who use replacement hormones

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sexual Function: A set of sexual responses and reactions including sexual desire, satisfaction, vaginal lubrication, orgasm and pain in sexual intercourse with the spouse, which is determined by the Sexual Function Index Questionnaire with a FSFI score greater than or equal to 26.5 Desirable Sexual Function and FSFI score less than 26.5 is considered sexual dysfunction and people with FSFI score less than 26.5 are included in the study. Timepoint: Day zero and 43. Method of measurement: FSFI questionnaire.;Sexual satisfaction: means the objective feelings of satisfaction, satisfaction, and enjoyment experienced by a spouse when considering all aspects of their marriage. Persons who, according to the Larsson Questionnaire of Sexual dissatisfaction (score 50 and below), low sexual satisfaction (score51-75) they enter the study. Timepoint: Day zero and 43. Method of measurement: Larson questionnaire.
Secondary Outcome Measures
NameTimeMethod
Testosterone levels. Timepoint: Before the study and day 43. Method of measurement: The radioimmunoassay method.
© Copyright 2025. All Rights Reserved by MedPath